June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Teleretinal Screening in Mexico: a Pilot Project as part of a Comprehensive Diabetes Care Clinic in Monterrey, México
Author Affiliations & Notes
  • Gilberto Zamora
    VisionQuest Biomedical, LLC, Albuquerque, NM
  • Javier Lozano
    Clínicas del Azúcar S.A.P.I. de C.V., Monterrey, Mexico
  • Richard VanNess
    VisionQuest Biomedical, LLC, Albuquerque, NM
  • Sheila Nemeth
    VisionQuest Biomedical, LLC, Albuquerque, NM
  • Omar Meza
    Clínicas del Azúcar S.A.P.I. de C.V., Monterrey, Mexico
  • Eduardo Martiñón
    Clínicas del Azúcar S.A.P.I. de C.V., Monterrey, Mexico
  • Elizabeth McGrew
    VisionQuest Biomedical, LLC, Albuquerque, NM
  • Peter Soliz
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
  • Footnotes
    Commercial Relationships Gilberto Zamora, VisionQuest Biomedical LLC (E); Javier Lozano, Clinicas del Azucar (E); Richard VanNess, VisionQuest i-Rx (E); Sheila Nemeth, Visionquest Biomedical LLC (E); Omar Meza, CLINICAS DEL AZUCAR (E); Eduardo Martiñón, clinicas del azucar (E); Elizabeth McGrew, VisionQuest Biomedical (E); Peter Soliz, VisionQuest Biomedical LLC (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1550. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gilberto Zamora, Javier Lozano, Richard VanNess, Sheila Nemeth, Omar Meza, Eduardo Martiñón, Elizabeth McGrew, Peter Soliz; Teleretinal Screening in Mexico: a Pilot Project as part of a Comprehensive Diabetes Care Clinic in Monterrey, México. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1550. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To conduct a proof of feasibility study for teleretinal screening services in a comprehensive diabetes care clinic in Monterrey, México.

Methods: A pilot project between VisionQuest Biomedical and Clínicas del Azúcar provides teleretinal screening services to the clinic’s patient members, who all have diabetes. Patients are imaged using a teleretinal screening system for assessment of diabetic retinopathy as part of their standard of care. The retinal camera is a Canon CR 2, 45-degree, non-mydriatic camera. The imaging protocol includes two images of the retina, one macula-centered and one optic-disc-centered, and one anterior image, for each eye. Images are uploaded automatically to a web-based PACS. Images are read according to the International Clinical Diabetic Retinopathy Grading Scale. Preliminary readings are provided by a certified ophthalmic medical technologist in Albuquerque (USA) within 48 hours. Licensed chronic disease medical doctors at Clínicas del Azúcar perform the final reading, sign off on all reports, and manage follow-up care for patients. Reports are entered into the patient’s EMR and used as part of a comprehensive diabetes care model that includes consultation with a psychologist, a nutritionist, and a chronic disease specialist, as well as diabetic foot screenings, blood work, and access to diabetes-friendly groceries. Follow up with ophthalmology for high-risk cases is arranged by the clinic.

Results: Total number of cases: 350. Percentage of findings by DR grade: no DR (39%), Mild DR (20%), Moderate DR (21%), Moderate DR with probable CSME (3%), Severe DR (5%), PDR (4%), S/Laser PDR (8%). Other Findings: Hypertensive Retinopathy (20%)

Conclusions: The first phase of our pilot project demonstrates that it is feasible and effective to establish a teleretinal screening service in Mexico as part of a new model for comprehensive diabetes care unlike anything in México or others parts of the world.

Keywords: 499 diabetic retinopathy • 463 clinical (human) or epidemiologic studies: prevalence/incidence • 498 diabetes  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×